|
1
|
Takagi S, Tsuji T, Amagai T, Takamatsu T
and Fujisawa H: Specific cell surface labels in the visual centers
of Xenopus laevis tadpole identified using monoclonal antibodies.
Dev Biol. 122:90–100. 1987.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fujisawa H, Ohtsuki T, Takagi S and Tsuji
T: An aberrant retinal pathway and visual centers in Xenopus
tadpoles share a common cell surface molecule, A5 antigen. Dev
Biol. 135:231–240. 1989.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kolodkin AL, Levengood DV, Rowe EG, Tai
YT, Giger RJ and Ginty DD: Neuropilin is a semaphorin III receptor.
Cell. 90:753–762. 1997.PubMed/NCBI View Article : Google Scholar
|
|
4
|
He Z and Tessier-Lavigne M: Neuropilin is
a receptor for the axonal chemorepellent Semaphorin III. Cell.
90:739–751. 1997.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Soker S, Takashima S, Miao HQ, Neufeld G
and Klagsbrun M: Neuropilin-1 is expressed by endothelial and tumor
cells as an isoform-specific receptor for vascular endothelial
growth factor. Cell. 92:735–745. 1998.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cantuti-Castelvetri L, Ojha R, Pedro LD,
Djannatian M, Franz J, Kuivanen S, van der Meer F, Kallio K, Kaya
T, Anastasina M, et al: Neuropilin-1 facilitates SARS-CoV-2 cell
entry and infectivity. Science. 370:856–860. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Daly JL, Simonetti B, Klein K, Chen KE,
Williamson MK, Antón-Plágaro C, Shoemark DK, Simón-Gracia L, Bauer
M, Hollandi R, et al: Neuropilin-1 is a host factor for SARS-CoV-2
infection. Science. 370:861–865. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mayi BS, Leibowitz JA, Woods AT, Ammon KA,
Liu AE and Raja A: The role of neuropilin-1 in COVID-19. PLoS
Pathog. 17(e1009153)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pal D, De K, Yates TB, Kolape J and
Muchero W: Mutating novel interaction sites in NRP1 reduces
SARS-CoV-2 spike protein internalization. iScience.
26(106274)2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Coutard B, Valle C, de Lamballerie X,
Canard B, Seidah NG and Decroly E: The spike glycoprotein of the
new coronavirus 2019-nCoV contains a furin-like cleavage site
absent in CoV of the same clade. Antiviral Res.
176(104742)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Katopodis P, Randeva HS, Spandidos DA,
Saravi S, Kyrou I and Karteris E: Host cell entry mediators
implicated in the cellular tropism of SARS-CoV-2, the
pathophysiology of COVID-19 and the identification of microRNAs
that can modulate the expression of these mediators (review). Int J
Mol Med. 49(20)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang S, Zhao L, Zhang X, Zhang J, Shang H
and Liang G: Neuropilin-1, a myeloid cell-specific protein, is an
inhibitor of HIV-1 infectivity. Proc Natl Acad Sci USA.
119(e2114884119)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chapoval SP and Keegan AD: Perspectives
and potential approaches for targeting neuropilin 1 in SARS-CoV-2
infection. Mol Med. 27(162)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ackermann M, Verleden SE, Kuehnel M,
Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H,
Tzankov A, et al: Pulmonary vascular endothelialitis, thrombosis,
and angiogenesis in Covid-19. N Engl J Med. 383:120–128.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mercurio AM: VEGF/neuropilin signaling in
cancer stem cells. Int J Mol Sci. 20(490)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rachner TD, Kasimir-Bauer S, Goebel A,
Erdmann K, Hoffmann O, Rauner M, Hofbauer LC, Kimmig R and Bittner
AK: Soluble neuropilin-1 is an independent marker of poor prognosis
in early breast cancer. J Cancer Res Clin Oncol. 147:2233–2238.
2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nasarre C, Roth M, Jacob L, Roth L,
Koncina E, Thien A, Labourdette G, Poulet P, Hubert P, Crémel G, et
al: Peptide-based interference of the transmembrane domain of
neuropilin-1 inhibits glioma growth in vivo. Oncogene.
29:2381–2392. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang HB, Zhang H, Zhang JP, Li Y, Zhao B,
Feng GK, Du Y, Xiong D, Zhong Q, Liu WL, et al: Neuropilin 1 is an
entry factor that promotes EBV infection of nasopharyngeal
epithelial cells. Nat Commun. 6(6240)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen M, Wang MH, Shen XG, Liu H, Zhang YY,
Peng JM, Meng F, Wang TY, Bai YZ, Sun MX, et al: Neuropilin-1
facilitates pseudorabies virus replication and viral glycoprotein B
promotes its degradation in a furin-dependent manner. J Virol.
96(e0131822)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lane RK, Guo H, Fisher AD, Diep J, Lai Z,
Chen Y, Upton JW, Carette J, Mocarski ES and Kaiser WJ:
Necroptosis-based CRISPR knockout screen reveals neuropilin-1 as a
critical host factor for early stages of murine cytomegalovirus
infection. Proc Natl Acad Sci USA. 117:20109–20116. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ghez D, Lepelletier Y, Lambert S, Fourneau
JM, Blot V, Janvier S, Arnulf B, van Endert PM, Heveker N, Pique C
and Hermine O: Neuropilin-1 is involved in human T-cell
lymphotropic virus type 1 entry. J Virol. 80:6844–6854.
2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kolarič A, Jukič M and Bren U: Novel
small-molecule inhibitors of the SARS-CoV-2 spike protein binding
to neuropilin 1. Pharmaceuticals (Basel). 15(165)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Charoute H, Elkarhat Z, Elkhattabi L, El
Fahime E, Oukkache N, Rouba H and Barakat A: Computational
screening of potential drugs against COVID-19 disease: The
neuropilin-1 receptor as molecular target. Virusdisease. 33:23–31.
2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Alshawaf E, Hammad MM, Marafie SK, Ali H,
Al-Mulla F, Abubaker J and Mohammad A: Discovery of natural
products to block SARS-CoV-2 S-protein interaction with
neuropilin-1 receptor: A molecular dynamics simulation approach.
Microb Pathog. 170(105701)2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ganguly A, Mandi M, Dutta A and Rajak P:
In silico analysis reveals the inhibitory potential of madecassic
acid against entry factors of SARS-CoV-2. ACS Appl Bio Mater.
6:652–662. 2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Karkashan A and Attar R: Computational
screening of natural products to identify potential inhibitors for
human neuropilin-1 (NRP1) receptor to abrogate the binding of
SARS-CoV-2 and host cell. J Biomol Struct Dyn. 41:9987–9996.
2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Škrbić R, Travar M, Stojiljković MP,
Djuric DM and Suručić R: Folic Acid and leucovorin have potential
to prevent SARS-CoV-2-virus internalization by interacting with
S-glycoprotein/neuropilin-1 receptor complex. Molecules.
28(2294)2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hashizume M, Takashima A, Ono C, Okamoto T
and Iwasaki M: Phenothiazines inhibit SARS-CoV-2 cell entry via a
blockade of spike protein binding to neuropilin-1. Antiviral Res.
209(105481)2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Perez-Miller S, Patek M, Moutal A, Duran
P, Cabel CR, Thorne CA, Campos SK and Khanna R: Novel compounds
targeting neuropilin receptor 1 with potential to interfere with
SARS-CoV-2 virus entry. ACS Chem Neurosci. 12:1299–1312.
2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li D, Liu X, Zhang L, He J, Chen X, Liu S,
Fu J, Fu S, Chen H, Fu J and Cheng J: COVID-19 disease and
malignant cancers: The impact for the furin gene expression in
susceptibility to SARS-CoV-2. Int J Biol Sci. 17:3954–3967.
2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fu J, Wei C, He J, Zhang L, Zhou J, Balaji
KS, Shen S, Peng J, Sharma A and Fu J: Evaluation and
characterization of HSPA5 (GRP78) expression profiles in normal
individuals and cancer patients with COVID-19. Int J Biol Sci.
17:897–910. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Uhlen M, Zhang C, Lee S, Sjöstedt E,
Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, et
al: A pathology atlas of the human cancer transcriptome. Science.
357(eaan2507)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45
(W1):W98–W102. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347(1260419)2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wang K, Deng H, Song B, He J, Liu S, Fu J,
Zhang L, Li D, Balaji KS, Mei Z, et al: The correlation between
immune invasion and SARS-COV-2 entry protein ADAM17 in cancer
patients by bioinformatic analysis. Front Immunol.
13(923516)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang L, Wei C, Li D, He J, Liu S, Deng H,
Cheng J, Du J, Liu X, Chen H, et al: COVID-19 receptor and
malignant cancers: Association of CTSL expression with
susceptibility to SARS-CoV-2. Int J Biol Sci. 18:2362–2371.
2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Fu J, Zhou B, Zhang L, Balaji KS, Wei C,
Liu X, Chen H, Peng J and Fu J: Expressions and significances of
the angiotensin-converting enzyme 2 gene, the receptor of
SARS-CoV-2 for COVID-19. Mol Biol Rep. 47:4383–4392.
2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Untergasser A, Cutcutache I, Koressaar T,
Ye J, Faircloth BC, Remm M and Rozen SG: Primer3-new capabilities
and interfaces. Nucleic Acids Res. 40(e115)2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Elkrief A, Hennessy C, Kuderer NM,
Rubinstein SM, Wulff-Burchfield E, Rosovsky RP, Vega-Luna K,
Thompson MA, Panagiotou OA, Desai A, et al: Geriatric risk factors
for serious COVID-19 outcomes among older adults with cancer: A
cohort study from the COVID-19 and Cancer Consortium. Lancet
Healthy Longev. 3:e143–e152. 2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Desai A, Gupta R, Advani S, Ouellette L,
Kuderer NM, Lyman GH and Li A: Mortality in hospitalized patients
with cancer and coronavirus disease 2019: A systematic review and
meta-analysis of cohort studies. Cancer. 127:1459–1468.
2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Grivas P, Khaki AR, Wise-Draper TM, French
B, Hennessy C, Hsu CY, Shyr Y, Li X, Choueiri TK, Painter CA, et
al: Association of clinical factors and recent anticancer therapy
with COVID-19 severity among patients with cancer: A report from
the COVID-19 and cancer consortium. Ann Oncol. 32:787–800.
2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Fu C, Stoeckle JH, Masri L, Pandey A, Cao
M, Littman D, Rybstein M, Saith SE, Yarta K, Rohatgi A, et al:
COVID-19 outcomes in hospitalized patients with active cancer:
Experiences from a major New York City health care system. Cancer.
127:3466–3475. 2021.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Blume C, Jackson CL, Spalluto CM, Legebeke
J, Nazlamova L, Conforti F, Perotin JM, Frank M, Butler J, Crispin
M, et al: A novel ACE2 isoform is expressed in human respiratory
epithelia and is upregulated in response to interferons and RNA
respiratory virus infection. Nat Genet. 53:205–214. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Onabajo OO, Banday AR, Stanifer ML, Yan W,
Obajemu A, Santer DM, Florez-Vargas O, Piontkivska H, Vargas JM,
Ring TJ, et al: Interferons and viruses induce a novel truncated
ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat
Genet. 52:1283–1293. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lu ZZ, Sun C, Zhang X, Peng Y, Wang Y,
Zeng Y, Zhu N, Yuan Y and Zeng MS: Neuropilin 1 is an entry
receptor for KSHV infection of mesenchymal stem cell through
TGFBR1/2-mediated macropinocytosis. Sci Adv.
9(eadg1778)2023.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Moore PS and Chang Y: Detection of
herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with
and those without HIV infection. N Engl J Med. 332:1181–1185.
1995.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Soulier J, Grollet L, Oksenhendler E,
Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael
M, Degos L, et al: Kaposi's sarcoma-associated herpesvirus-like DNA
sequences in multicentric Castleman's disease. Blood. 86:1276–1280.
1995.PubMed/NCBI
|
|
48
|
Cesarman E, Chang Y, Moore PS, Said JW and
Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA
sequences in AIDS-related body-cavity-based lymphomas. N Engl J
Med. 332:1186–1191. 1995.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Chen Q, Chen J, Li Y, Liu D, Zeng Y, Tian
Z, Yunus A, Yang Y, Lu J, Song X and Yuan Y: Kaposi's sarcoma
herpesvirus is associated with osteosarcoma in Xinjiang
populations. Proc Natl Acad Sci USA.
118(e2016653118)2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Morin E, Lindskog C, Johansson M, Egevad
L, Sandström P, Harmenberg U, Claesson-Welsh L and Sjöberg E:
Perivascular neuropilin-1 expression is an independent marker of
improved survival in renal cell carcinoma. J Pathol. 250:387–396.
2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Choong OK, Jakobsson R, Bergdahl AG,
Brunet S, Kärmander A, Waldenström J, Arvidsson Y, Altiparmak G,
Nilsson JA, Karlsson J, et al: SARS-CoV-2 replicates and displays
oncolytic properties in clear cell and papillary renal cell
carcinoma. PLoS One. 18(e0279578)2023.PubMed/NCBI View Article : Google Scholar
|
